# Shifamed

Shifamed is an Asset Manager based in Campbell, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Campbell, United States
- **Region:** Europe
- **Address:** Campbell, CA, United States
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** shifamed.com
- **LinkedIn:** https://www.linkedin.com/company/shifamed

## Regulatory record

- **Reports private funds:** No

## About

Shifamed is a medical technology incubator that develops new medical products from concept to commercial release. It has made 32 investments, including a Series D investment in Supira Medical on November 21, 2023.

## Sectors

- MedTech
- Digital Health

## People

- Amr Salahieh — Founder & CEO

## Questions

### How does Shifamed source its investment opportunities?

Shifamed does not source external deals. The firm generates its own pipeline internally: the founding team identifies clinical problems, develops the initial technology and intellectual property, and then forms a new company to commercialize it. This makes deal flow fully proprietary and independent of traditional venture-origination channels (public record).

### Is Shifamed a venture capital fund?

No. Shifamed is a privately funded incubator and holding entity. It does not raise committed capital from limited partners, does not charge management fees, and does not operate on a fund cycle. Each portfolio company is a legally independent entity in which Shifamed and co-investors hold equity (per the firm's official communications).

### Who runs investment decisions at Shifamed?

Founder and CEO Amr Salahieh controls all strategic and investment decisions. He personally determines which technologies advance to company formation and which co-investors participate in each spinout (per the firm's official communications).

### Does Shifamed participate in fund commitments or only direct deals?

Shifamed only makes direct, equity-holding investments in companies it creates internally. It does not commit capital to third-party venture funds, nor does it act as a limited partner in external vehicles (public record).

### What happened to Shockwave Medical and why is that significant?

Shockwave Medical, a Shifamed-founded company that developed intravascular lithotripsy for calcified arterial disease, was acquired by Johnson & Johnson for $13.1 billion in a deal that closed in 2024 (per Bloomberg, 2023). The exit validated Shifamed's concentrated incubation model and returned substantial capital to its founding stakeholders.

### How is Shifamed structured in relation to its portfolio companies?

Each portfolio company is a legally distinct entity with its own management team, board, and capitalization structure. Shifamed holds an equity stake in each but does not operate them as subsidiaries. This allows companies to raise independent financing and pursue their own exit paths (per the firm's official communications).

## Related profiles

- [CNH Industrial](https://altss.com/profile/cnh-industrial-nv)
- [Highgate Hotels](https://altss.com/profile/highgate-hotels)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/shifamed

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology